NRX Pharmaceuticals, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2025-03-07: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; Date of first sale 2025-01-27; Total offering amount $3,500,000.
- 2017-11-22: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2017-09-26; Total offering amount $2,750,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|
| 2025-03-07 | Rule 506(b) | OptionToAcquire | 2025-01-27 | $3,500,000 | $3,500,000 | $0 | 2 |
|---|
| 2017-11-22 | Rule 506(b) | Equity; OptionToAcquire; SecurityToBeAcquired | 2017-09-26 | $2,750,000 | $2,525,000 | $225,000 | 1 |
|---|